From: A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Characteristics | Tota l(N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 97 | 1.030 (1.004–1.057) | 0.022 | 1.052 (1.015–1.090) | 0.006 |
Gender | 97 | Â | Â | Â | Â |
 Male | 74 | Reference |  |  |  |
 Female | 23 | 1.070 (0.617–1.857) | 0.809 |  |  |
T stage | 97 | Â | Â | Â | Â |
 T1 | 9 | Reference |  |  |  |
 T2 | 17 | 1.441 (0.373–5.574) | 0.596 | 0.883 (0.172–4.536) | 0.881 |
 T3 | 46 | 3.515 (1.076–11.486) | 0.037 | 1.234 (0.280–5.446) | 0.781 |
 T4 | 25 | 9.291 (2.754–31.351) |  < 0.001 | 2.270 (0.471–10.936) | 0.307 |
N stage | 97 | Â | Â | Â | Â |
 N0 | 27 | Reference |  |  |  |
 N1 | 14 | 0.680 (0.266–1.737) | 0.420 | 0.751 (0.239–2.356) | 0.624 |
 N2 | 25 | 1.547 (0.788–3.040) | 0.205 | 1.348 (0.605–3.005) | 0.465 |
 N3 | 31 | 2.793 (1.492–5.228) | 0.001 | 2.058 (0.816–5.192) | 0.126 |
M stage | 97 | Â | Â | Â | Â |
 M0 | 84 | Reference |  |  |  |
 M1 | 13 | 8.343 (4.140–16.812) |  < 0.001 | 5.224 (1.856–14.704) | 0.002 |
Pathologic stage | 96 | Â | Â | Â | Â |
 II | 23 | Reference |  |  |  |
 II–III | 28 | 1.293 (0.678–2.463) | 0.435 |  |  |
 III | 45 | 1.029 (0.559–1.895) | 0.927 |  |  |
Differentiation | 97 | Â | Â | Â | Â |
 Poorly | 49 | Reference |  |  |  |
 Moderate | 38 | 0.683 (0.404–1.155) | 0.155 |  |  |
 Well | 5 | 0.466 (0.143–1.517) | 0.205 |  |  |
 Unknown | 5 | 1.501 (0.586–3.847) | 0.398 |  |  |
Tumor diameter(cm) | 95 | Â | Â | Â | Â |
  ≤ 3 | 38 | Reference |  |  |  |
 3–5 | 42 | 1.366 (0.799–2.333) | 0.254 | 1.085 (0.577–2.037) | 0.801 |
  > 5 | 15 | 2.259 (1.127–4.531) | 0.022 | 1.108 (0.414–2.962) | 0.839 |
Location | 97 | Â | Â | Â | Â |
 Cardia | 2 | Reference |  |  |  |
 Cardia-corpus | 2 | 79237078.175 (0.000-Inf) | 0.996 |  |  |
 Cardia-fundus | 12 | 25653907.317 (0.000-Inf) | 0.996 |  |  |
 Fundus | 1 | 1.000 (0.000-Inf) | 1.000 |  |  |
 Gastric antrum | 65 | 26698640.929 (0.000-Inf) | 0.996 |  |  |
 Gastric corpus | 13 | 33039305.878 (0.000-Inf) | 0.996 |  |  |
 Others | 2 | 20383228.678 (0.000-Inf) | 0.996 |  |  |
Surgical methods | 96 | Â | Â | Â | Â |
 Distal gastrectomy | 64 | Reference |  |  |  |
 Proximal gastrectomy | 16 | 0.968 (0.487–1.925) | 0.926 |  |  |
 Total gastrectomy | 14 | 1.753 (0.904–3.398) | 0.097 |  |  |
 Others | 2 | 1.578 (0.382–6.522) | 0.529 |  |  |
AFP | 78 | 1.009 (1.002–1.017) | 0.018 | 1.015 (1.006–1.024) |  < 0.001 |
CEA | 78 | 1.005 (0.995–1.016) | 0.313 |  |  |
CA199 | 78 | 1.000 (0.999–1.002) | 0.578 |  |  |
CA153 | 77 | 1.010 (0.987–1.033) | 0.406 |  |  |
CA125 | 77 | 1.000 (0.994–1.007) | 0.954 |  |  |
H pylori infection | 74 | Â | Â | Â | Â |
 ( +) | 37 | Reference |  |  |  |
 (−) | 37 | 1.205 (0.699–2.076) | 0.503 |  |  |
IOD of BTG2 | 97 | 1.000 (0.986–1.015) | 0.969 |  |  |